Latest News

  • TECHNOLOGY

    18 Feb 2026

    How the Cloud Powers the Next mRNA Breakthrough

  • INSIGHTS

    16 Feb 2026

    Can Europe Win the mRNA Cancer Race?

  • REGULATORY

    12 Feb 2026

    FDA Refusal-to-File Resets mRNA Flu Strategy

  • INNOVATION

    11 Feb 2026

    Britain’s Bet On Better RNA Factories

Moderna and Recordati Bet on mRNA Beyond Vaccines

Syringe labeled Moderna mRNA-3927 with Recordati logo in background

PARTNERSHIPS

10 Feb 2026

Moderna and Recordati partner on an mRNA therapy for propionic acidemia, combining resources to accelerate development

Concept image illustrating generative AI applied to mRNA drug design

TECHNOLOGY

7 Jan 2026

Can Generative AI Crack the Code of mRNA Design?

New preclinical data suggest generative AI could streamline mRNA design and reduce costly trial-and-error for future therapies

Icahn School of Medicine at Mount Sinai where researchers develop selective mRNA drug designs

RESEARCH

19 Dec 2025

A New Twist Makes mRNA Drugs More Selective

Preclinical US research in mouse models suggest redesigned mRNA activates mainly in diseased cells, hinting at safer drugs as human trials...

HHS press release signaling reduced BARDA support for mRNA development

REGULATORY

18 Dec 2025

BARDA Pullback Signals New Phase for US mRNA Development

HHS is winding down BARDA-backed mRNA vaccine programs, prompting analysts to see a shift toward commercially focused mRNA strategies

Aerial view of the University of Texas campus where new AI mRNA research was developed.

INNOVATION

17 Dec 2025

mRNA Design Enters a More Predictive Era

New AI research forecasts mRNA protein output earlier, helping developers refine drug designs before costly lab testing begins

Crowd gathered outside Moderna headquarters building in daylight

INVESTMENT

15 Dec 2025

Moderna Bets on Debt to Power mRNA’s Next Act

Moderna secures a $1.5B non-dilutive term loan to fund mRNA growth beyond COVID, highlighting why established players may prioritize long-...

Illustration of syringe targeting virus cell, symbolizing mRNA cancer vaccine research

INNOVATION

12 Dec 2025

mRNA Finds a New Role in Personalised Cancer Care

Phase 2b melanoma data fuels interest in personalized mRNA vaccines, highlighting design agility while raising new questions about scale, ...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.